Jimenez, Cyril James .
HRN: 08-02-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2024
OXACILLIN 500MG (VIAL)
10/28/2024
11/04/2024
IV
500mg
Q6
Tbi
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes